Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

Chang, 2009, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study, J Natl Cancer Inst, 101, 1348, 10.1093/jnci/djp288

2011

Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516

Pisani, 1997, Cancer and infection: estimates of the attributable fraction in 1990, Cancer Epidemiol Biomarkers Prev, 6, 387

Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731

Bouvard, 2009, A review of human carcinogens–Part B: biological agents, Lancet Oncol, 10, 321, 10.1016/S1470-2045(09)70096-8

2009

Ferlay, 2010

Parkin, 2002

Curado, 2007

Miettinen, 1974, Proportion of disease caused or prevented by a given exposure, trait or intervention, Am J Epidemiol, 99, 325, 10.1093/oxfordjournals.aje.a121617

2001, Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts, Gut, 49, 347, 10.1136/gut.49.3.347

Donato, 1998, A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma, Int J Cancer, 75, 347, 10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2

Dondog, 2011, Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia, Eur J Cancer Prev, 20, 33, 10.1097/CEJ.0b013e32833f0c8e

Dal Maso, 2006, Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies, Cancer Epidemiol Biomarkers Prev, 15, 2078, 10.1158/1055-9965.EPI-06-0308

Backes, 2009, Systematic review of human papillomavirus prevalence in invasive penile cancer, Cancer Causes Control, 20, 449, 10.1007/s10552-008-9276-9

De Vuyst, 2009, Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis, Int J Cancer, 124, 1626, 10.1002/ijc.24116

Parkin, 2011, Cancers attributable to infections in the UK in 2010, Br J Cancer, 105, 49, 10.1038/bjc.2011.484

Shin, 2011, Population attributable fraction of infection-related cancers in Korea, Ann Oncol, 22, 1435, 10.1093/annonc/mdq592

Xiang, 2011, Estimation of cancer cases and deaths attributable to infection in China, Cancer Causes Control, 22, 1153, 10.1007/s10552-011-9791-y

Mitchell, 2008, Immunoblotting using multiple antigens is essential to demonstrate the true risk of Helicobacter pylori infection for gastric cancer, Aliment Pharmacol Ther, 28, 903, 10.1111/j.1365-2036.2008.03792.x

Ekstrom, 2001, Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection, Gastroenterology, 121, 784, 10.1053/gast.2001.27999

Brenner, 2004, Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?, Am J Epidemiol, 159, 252, 10.1093/aje/kwh039

Herrera, 2009, Helicobacter pylori and gastric adenocarcinoma, Clin Microbiol Infect, 15, 971, 10.1111/j.1469-0691.2009.03031.x

Siman, 2007, Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma, Scand J Gastroenterol, 42, 933, 10.1080/00365520601173863

2010